blood biomarkers
-
Alzheimer’s disease, blood biomarkers, Brain, capillary blood sampling, cognition, cognitive impairment, dementia screening, fingerprick test, GFAP, Neurodegenerative Diseases, neuroscience, p-tau217, PROTECT study, remote testingAlzheimer’s Fingerprick Blood Biomarkers: p-tau217 and GFAP Track Cognition
A 2026 PROTECT study involving 174 older adults found that self-administered fingerprick…
-
blood biomarkers, Brain, brain aging, cognition, dementia biomarkers, genetics, hippocampal atrophy, microrna, miR-199a-3p, miR-361-3p, Neurodegenerative Diseases, Rhineland StudyBlood microRNAs Linked to Hippocampal Atrophy in Rhineland Study
A 2026 Molecular Psychiatry analysis from the Rhineland Study found that blood-derived…
-
A-beta 42/40, Alzheimer’s disease, amyloid PET, blood biomarkers, Brain, Clarity AD, cognition, GFAP, lecanemab, maintenance dosing, Neurodegenerative Diseases, p-tau181, PK/PD modelingLecanemab Blood Biomarkers Rebound Faster Than Amyloid PET After Stopping
Lecanemab blood biomarkers may rebound much faster than amyloid PET after treatment…
-
Alzheimer’s disease, amygdala, blood biomarkers, Brain, cognition, cognitive impairment, dementia biomarkers, hippocampus, MRI radiomics, Neurodegenerative Diseases, neuroscience, olfactory dysfunction, pTau217Olfactory MRI Radiomics Link pTau217 to Alzheimer’s Cognition
A 2026 multi-cohort Alzheimer’s disease study found that MRI radiomics from the…
-
blood biomarkers, Brain, demyelination, disease activity, medRxiv preprint, multiple sclerosis, myelin oligodendrocyte glycoprotein, Neurodegenerative Diseases, neurofilament light chain, neuroscience, relapse, remission, serum MOGSerum MOG Blood Biomarker Rose During Multiple Sclerosis Relapse
A 2026 medRxiv case-control study found that serum myelin oligodendrocyte glycoprotein was…
